Brief: Parnell Pharmaceuticals Q1 EPS $0.004
22/04/2015 12:00
April 22 (Reuters) - Parnell Pharmaceuticals Holdings Ltd PARN.O : * Announces first quarter business results * Q1 earnings per share $0.004 * Says total revenues increased by 6% for the three months ended March 31, 2015, * Qtrly revenue A$1.6 million versus A$1.5 million * Source text for Eikon ID:nGNXVDIDCa * Further company coverage PARN.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Parnell Pharmaceuticals Holdings
See all newsBrief: Parnell Pharmaceuticals announces intention to move from Nasdaq OMX global market
Brief: Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million
Brief: Parnell Pharmaceuticals says manufacturing deal with Merial
Brief: Parnell Pharmaceuticals announces pricing of underwritten public offering
Brief: Parnell Pharmaceuticals Q1 revenue rose 43 percent to $2.2 mln